Recruiting now
-
A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer
Phase 2 · 44 people · 1 site in China · Recruiting now
-
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Phase 2 · 48 people · 1 site in China · Recruiting now
-
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Phase 2 · 220 people · 24 sites in 7 countries · Recruiting now
-
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Phase 2 · 400 people · 41 sites in France · Recruiting now
-
Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
Phase 2 · 37 people · 1 site in China · Recruiting now
-
Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer
Not phased · randomised · 168 people · 1 site in China · Recruiting now